MEXICO CITY, MEXICO – March 2, 2005 – Pharm-Olam International Ltd. (POI) is pleased to announce the completion of its newest office in Mexico City, Mexico. This new facility will enable POI to meet the accelerated growth in clinical research, regulatory affairs, drug storage and archiving requirements for its valued clients.

Pharm-Olam de Mexico is located at Boulevard Adolfo Ruiz Cortinez 3453, Torre B, Despacho 901, Colonia San Jeronimo Lidice, C.P. 10200, Delegacion Magdalena Contreras.

POI has recognized Mexico as a key, clinical trial sector in the Latin American, and has been conducting studies in Mexico since 2001. POI-Mexico currently performs phase I through III studies for various therapeutic areas including cancer, woman’s health and cardiovascular diseases. Pharm-Olam de Mexico has also added an early-phase, clinical development program for proof-of-concept studies utilizing a network of phase I units.

Pharm-Olam International is a multi-national, contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. POI is focused on delivering high-quality data, achieving targeted enrollment and meeting projected timelines. Please contact Pharm-Olam International Ltd. for more information. Focusing On Results.